lobbying_activities: 2307555

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2307555	295cd029-5684-4e30-b130-f32999bf622f	Q2	KOUNTOUPES DENHAM CARR & REID, LLC	320918	CVS HEALTH	2019	second_quarter	PHA	General education about the pharmacy benefit manager/pharmacy industry, including S.476, The Creating Transparency to Have Drug Rebates Unlocked (C-THRU)Act. Issues related to Risk Evaluation and Mitigation Strategies (REMS) program, including S.340 and H. R. 965, The CREATES Act. S. 1895, Lower Health Case Costs Act; S.1227, The Prescription Pricing for the People Act of 2019.	HOUSE OF REPRESENTATIVES,SENATE,White House Office	60000		0	0	2019-07-17T14:21:21.340000-04:00